Getinge announces date of 2012 Q3 report and conference call


GETINGE will issue its Q3 report for 2012 on Wednesday 17th of October 2012 at
12:00 CET, followed by a conference call at 15:00 CET, hosted by Johan
Malmquist, CEO, and Ulf Grunander, CFO.

To participate in the conference, please dial:
Swedish dial in number: +46 (0) 8 5876 9446
UK dial in number: +44 (0) 20 3106 4822
US dial in number: +1 646 254 3366
Participant passcode: 8164231

Agenda
14:45 Call in to the conference
15:00 Review of the Q3 report
15:20 Q&A
16:00 Close of the conference

A recorded version of the conference can be accessed for 5 working days on the
following number:
Sweden: +46 (0) 8 5051 3897
UK: +44 (0) 20 7111 1244
US: +1 347 366 9565
Code: 8164231

During the telephone conference a presentation will be held. To access the
presentation, please use this link:
http://www.livemeeting.com/cc/premconfeurope/join?id=8164231&role=attend&pw=pw56
4 
3

Alternatively enter the VisionCast site and log into your meeting using the
Meeting ID and Password below:
VisionCast: http://www.euvisioncast.com
Your Name: (Enter your name)
Web Meeting ID: 8164231
Web Meeting Password: pw5643

For more information, please contact:
Kornelia Rasmussen
Group Communications
Phone: +46 (0)10 335 5810
E-mail: kornelia.rasmussen@getinge.com

GETINGE GROUP is a leading global provider of products and systems that
contribute to quality enhancement and cost efficiency within healthcare and life
sciences. We operate under the three brands of ArjoHuntleigh, GETINGE and
MAQUET. ArjoHuntleigh focuses on patient mobility and wound management
solutions. GETINGE provides solutions for infection control within healthcare
and contamination prevention within life sciences. MAQUET specializes in
solutions, therapies and products for surgical interventions, interventional
cardiology and intensive care.

The information is such that Getinge AB must disclose in accordance with the
Swedish Securities Market Act and/or the Financial Instruments Trading Act.

Pièces jointes

10047633.pdf
GlobeNewswire